Innovation, partnerships and best practices: Priorities for biopharma in 2025
Industry experts highlight the progress made by the Indian biopharma sector, and suggest pathways to promote growth
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Amit Mookim
Immuneel Therapeutics welcomes Amit Mookim as CEO
Mookim will focus on establishing partnerships with providers, practitioners, and public health, and delivering current CART…
OPPI facilitates a panel discussion on National IPR Policy
It focused on interpreting the role of the policy in fostering a culture of innovation As part of its Golden Jubilee Celebration…